The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions
Description
The objective of this study is to quantify the impact of the COVID-19 pandemic on attention deficit hyperactivity disorder (ADHD) medication consumption globally and nationally using pharmaceutical sales data from 2014 to 2021 across 47 countries and
